TargetCancer Foundation

Our Story

Founded in 2009 by Paul Poth after his diagnosis with cholangiocarcinoma, TargetCancer Foundation is dedicated to advancing research and support for individuals affected by rare cancers. The foundation focuses on cancers that receive insufficient funding and attention, striving to create a more equitable landscape in cancer research.

Impact

With over $1 million in funding for rare cancer research, TargetCancer Foundation has initiated impactful programs like the TCF-001 TRACK clinical trial, enrolling patients in innovative precision medicine studies. The establishment of the Cholangiocarcinoma Cell Line Bank and numerous scientific meetings further fosters collaboration among researchers and advocates.

Why Donate?

Your donation to TargetCancer Foundation supports critical research initiatives aimed at developing effective treatments for rare cancers. Contributions help bridge the funding gap for under-resourced cancer types, ensuring patients have access to innovative therapies and support services.

Get Involved

Join the fight against rare cancers by donating today! Your support can make a significant difference in the lives of those affected by these diseases. Whether through cryptocurrency or cash, every contribution counts towards advancing scientific discovery and providing hope.